Results of implementation of viral hepatitis B elimination program in the North-West Russia

Introduction. Vaccination contributed to reduce the incidence of acute hepatitis B in the territories of the North-West Russia. The urgency of this problem remains due to the high incidence of chronic hepatitis B. This accounted for the need to develop a hepatitis B elimination program in the distri...

Full description

Bibliographic Details
Published in:Russian Journal of Infection and Immunity
Main Authors: Lyalina L.V., Esaulenko E.V., Khorkova E.V., Novak K.E., Ostankova Y.V., Serikova E.N., Vasilyev D.V., Gorziy E.S., Butskaya M.J., Kritskaya I.V., Buts L.V., Grebenkina E.V., Baydakova E.V., Smirnova N.A., Krasnopyorova M.A., Koltsov N.S., Kotovich L.M., Kalinina E.L., Galimov R.R., Kirkhar N.V., Cherepanova E.A., Totolian A.A.
Format: Article in Journal/Newspaper
Language:Russian
Published: SPb RAACI 2021
Subjects:
Online Access:https://iimmun.ru/iimm/article/view/1785
https://doi.org/10.15789/2220-7619-ROT-1785
id ftjiii:oai:iimmun.ru:article/1785
record_format openpolar
institution Open Polar
collection Russian Journal of Infection and Immunity (Infektsiya i immunitet)
op_collection_id ftjiii
language Russian
topic hepatitis B virus
morbidity
genotypes
vaccination
elimination
вирусный гепатит В
заболеваемость
генотипы
вакцинация
элиминация
spellingShingle hepatitis B virus
morbidity
genotypes
vaccination
elimination
вирусный гепатит В
заболеваемость
генотипы
вакцинация
элиминация
Lyalina L.V.
Esaulenko E.V.
Khorkova E.V.
Novak K.E.
Ostankova Y.V.
Serikova E.N.
Vasilyev D.V.
Gorziy E.S.
Butskaya M.J.
Kritskaya I.V.
Buts L.V.
Grebenkina E.V.
Baydakova E.V.
Smirnova N.A.
Krasnopyorova M.A.
Koltsov N.S.
Kotovich L.M.
Kalinina E.L.
Galimov R.R.
Kirkhar N.V.
Cherepanova E.A.
Totolian A.A.
Results of implementation of viral hepatitis B elimination program in the North-West Russia
topic_facet hepatitis B virus
morbidity
genotypes
vaccination
elimination
вирусный гепатит В
заболеваемость
генотипы
вакцинация
элиминация
description Introduction. Vaccination contributed to reduce the incidence of acute hepatitis B in the territories of the North-West Russia. The urgency of this problem remains due to the high incidence of chronic hepatitis B. This accounted for the need to develop a hepatitis B elimination program in the district discussed that was approved in 2013 by the head of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing. Objective is to characterize the results of the program for the elimination of acute hepatitis B virus implemented in the North-Western Federal District. Materials and methods. The 2010–2020 incidence rate of acute and chronic hepatitis B virus (HBV) infection in the regions of the North-West Russia was carried out. To determine HBV genotypes and subgenotypes, 160 blood plasma samples from patients with acute hepatitis B were studied using molecular genetic methods (PCR, sequencing). The prevalence of latent hepatitis B in various population groups was assessed. The 2016–2020 hepatitis B vaccination coverage and relevant serological monitoring in adults was carried out. Results. While implementing the program, it was found that the incidence rate of acute hepatitis B in the district decreased by 4.5-fold, revealing in 2020 no cases of the disease in 5 regions, with incidence rate in the 6 subfederal units being lower than 1.0 per 100,000 population. Moreover, the incidence rate for chronic hepatitis B decreased by 2.6 times. The 2020 vaccination coverage of children under 17 and adults in all territories comprised more than 95% and 90%, respectively. In addition, it was shown the circulation of genotypes D and A of hepatitis B virus is dominated by genotype D (91.8%), subgenotype D2 (47.8%). The prevalence of latent hepatitis B among migrants was 6.5%, pregnant women — 4.9%, hemodialysis patients — 1.7%. Conclusion. Implementation of the program on elimination of acute viral hepatitis B in the territory of the North-West Russia contributed to raise in the vaccination coverage in ...
format Article in Journal/Newspaper
author Lyalina L.V.
Esaulenko E.V.
Khorkova E.V.
Novak K.E.
Ostankova Y.V.
Serikova E.N.
Vasilyev D.V.
Gorziy E.S.
Butskaya M.J.
Kritskaya I.V.
Buts L.V.
Grebenkina E.V.
Baydakova E.V.
Smirnova N.A.
Krasnopyorova M.A.
Koltsov N.S.
Kotovich L.M.
Kalinina E.L.
Galimov R.R.
Kirkhar N.V.
Cherepanova E.A.
Totolian A.A.
author_facet Lyalina L.V.
Esaulenko E.V.
Khorkova E.V.
Novak K.E.
Ostankova Y.V.
Serikova E.N.
Vasilyev D.V.
Gorziy E.S.
Butskaya M.J.
Kritskaya I.V.
Buts L.V.
Grebenkina E.V.
Baydakova E.V.
Smirnova N.A.
Krasnopyorova M.A.
Koltsov N.S.
Kotovich L.M.
Kalinina E.L.
Galimov R.R.
Kirkhar N.V.
Cherepanova E.A.
Totolian A.A.
author_sort Lyalina L.V.
title Results of implementation of viral hepatitis B elimination program in the North-West Russia
title_short Results of implementation of viral hepatitis B elimination program in the North-West Russia
title_full Results of implementation of viral hepatitis B elimination program in the North-West Russia
title_fullStr Results of implementation of viral hepatitis B elimination program in the North-West Russia
title_full_unstemmed Results of implementation of viral hepatitis B elimination program in the North-West Russia
title_sort results of implementation of viral hepatitis b elimination program in the north-west russia
publisher SPb RAACI
publishDate 2021
url https://iimmun.ru/iimm/article/view/1785
https://doi.org/10.15789/2220-7619-ROT-1785
genre North-West Russia
genre_facet North-West Russia
op_source Russian Journal of Infection and Immunity; Vol 11, No 5 (2021); 875-886
Инфекция и иммунитет; Vol 11, No 5 (2021); 875-886
2313-7398
2220-7619
op_relation https://iimmun.ru/iimm/article/view/1785/1328
https://iimmun.ru/iimm/article/downloadSuppFile/1785/6986
https://iimmun.ru/iimm/article/downloadSuppFile/1785/6987
https://iimmun.ru/iimm/article/downloadSuppFile/1785/6988
https://iimmun.ru/iimm/article/downloadSuppFile/1785/6989
https://iimmun.ru/iimm/article/downloadSuppFile/1785/6990
https://iimmun.ru/iimm/article/downloadSuppFile/1785/6991
https://iimmun.ru/iimm/article/downloadSuppFile/1785/6992
https://iimmun.ru/iimm/article/downloadSuppFile/1785/6993
https://iimmun.ru/iimm/article/downloadSuppFile/1785/6994
https://iimmun.ru/iimm/article/downloadSuppFile/1785/6995
https://iimmun.ru/iimm/article/downloadSuppFile/1785/6996
https://iimmun.ru/iimm/article/downloadSuppFile/1785/7055
https://iimmun.ru/iimm/article/view/1785
doi:10.15789/2220-7619-ROT-1785
op_rights Copyright (c) 2021 Lyalina L.V., Esaulenko E.V., Khorkova E.V., Novak K.E., Ostankova Y.V., Serikova E.N., Vasilyev D.V., Gorziy E.S., Butskaya M.J., Kritskaya I.V., Buts L.V., Grebenkina E.V., Baydakova E.V., Smirnova N.A., Krasnopyorova M.A., Koltsov N.S., Kotovich L.M., Kalinina E.L., Galimov R.R., Kirkhar N.V., Cherepanova E.A., Totolian A.A.
https://creativecommons.org/licenses/by/4.0
op_doi https://doi.org/10.15789/2220-7619-ROT-1785
container_title Russian Journal of Infection and Immunity
container_volume 11
container_issue 5
container_start_page 875
op_container_end_page 886
_version_ 1775353615397945344
spelling ftjiii:oai:iimmun.ru:article/1785 2023-08-27T04:11:07+02:00 Results of implementation of viral hepatitis B elimination program in the North-West Russia Результаты реализации программы элиминации вирусного гепатита В на CевероЗападе России Lyalina L.V. Esaulenko E.V. Khorkova E.V. Novak K.E. Ostankova Y.V. Serikova E.N. Vasilyev D.V. Gorziy E.S. Butskaya M.J. Kritskaya I.V. Buts L.V. Grebenkina E.V. Baydakova E.V. Smirnova N.A. Krasnopyorova M.A. Koltsov N.S. Kotovich L.M. Kalinina E.L. Galimov R.R. Kirkhar N.V. Cherepanova E.A. Totolian A.A. 2021-09-01 application/pdf https://iimmun.ru/iimm/article/view/1785 https://doi.org/10.15789/2220-7619-ROT-1785 rus rus SPb RAACI https://iimmun.ru/iimm/article/view/1785/1328 https://iimmun.ru/iimm/article/downloadSuppFile/1785/6986 https://iimmun.ru/iimm/article/downloadSuppFile/1785/6987 https://iimmun.ru/iimm/article/downloadSuppFile/1785/6988 https://iimmun.ru/iimm/article/downloadSuppFile/1785/6989 https://iimmun.ru/iimm/article/downloadSuppFile/1785/6990 https://iimmun.ru/iimm/article/downloadSuppFile/1785/6991 https://iimmun.ru/iimm/article/downloadSuppFile/1785/6992 https://iimmun.ru/iimm/article/downloadSuppFile/1785/6993 https://iimmun.ru/iimm/article/downloadSuppFile/1785/6994 https://iimmun.ru/iimm/article/downloadSuppFile/1785/6995 https://iimmun.ru/iimm/article/downloadSuppFile/1785/6996 https://iimmun.ru/iimm/article/downloadSuppFile/1785/7055 https://iimmun.ru/iimm/article/view/1785 doi:10.15789/2220-7619-ROT-1785 Copyright (c) 2021 Lyalina L.V., Esaulenko E.V., Khorkova E.V., Novak K.E., Ostankova Y.V., Serikova E.N., Vasilyev D.V., Gorziy E.S., Butskaya M.J., Kritskaya I.V., Buts L.V., Grebenkina E.V., Baydakova E.V., Smirnova N.A., Krasnopyorova M.A., Koltsov N.S., Kotovich L.M., Kalinina E.L., Galimov R.R., Kirkhar N.V., Cherepanova E.A., Totolian A.A. https://creativecommons.org/licenses/by/4.0 Russian Journal of Infection and Immunity; Vol 11, No 5 (2021); 875-886 Инфекция и иммунитет; Vol 11, No 5 (2021); 875-886 2313-7398 2220-7619 hepatitis B virus morbidity genotypes vaccination elimination вирусный гепатит В заболеваемость генотипы вакцинация элиминация info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion 2021 ftjiii https://doi.org/10.15789/2220-7619-ROT-1785 2023-08-08T20:22:46Z Introduction. Vaccination contributed to reduce the incidence of acute hepatitis B in the territories of the North-West Russia. The urgency of this problem remains due to the high incidence of chronic hepatitis B. This accounted for the need to develop a hepatitis B elimination program in the district discussed that was approved in 2013 by the head of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing. Objective is to characterize the results of the program for the elimination of acute hepatitis B virus implemented in the North-Western Federal District. Materials and methods. The 2010–2020 incidence rate of acute and chronic hepatitis B virus (HBV) infection in the regions of the North-West Russia was carried out. To determine HBV genotypes and subgenotypes, 160 blood plasma samples from patients with acute hepatitis B were studied using molecular genetic methods (PCR, sequencing). The prevalence of latent hepatitis B in various population groups was assessed. The 2016–2020 hepatitis B vaccination coverage and relevant serological monitoring in adults was carried out. Results. While implementing the program, it was found that the incidence rate of acute hepatitis B in the district decreased by 4.5-fold, revealing in 2020 no cases of the disease in 5 regions, with incidence rate in the 6 subfederal units being lower than 1.0 per 100,000 population. Moreover, the incidence rate for chronic hepatitis B decreased by 2.6 times. The 2020 vaccination coverage of children under 17 and adults in all territories comprised more than 95% and 90%, respectively. In addition, it was shown the circulation of genotypes D and A of hepatitis B virus is dominated by genotype D (91.8%), subgenotype D2 (47.8%). The prevalence of latent hepatitis B among migrants was 6.5%, pregnant women — 4.9%, hemodialysis patients — 1.7%. Conclusion. Implementation of the program on elimination of acute viral hepatitis B in the territory of the North-West Russia contributed to raise in the vaccination coverage in ... Article in Journal/Newspaper North-West Russia Russian Journal of Infection and Immunity (Infektsiya i immunitet) Russian Journal of Infection and Immunity 11 5 875 886